Mental Health

Ritten Announces $35M Series B Investment Led by Five Elms Capital

PHILADELPHIA, Dec. 11, 2025 /PRNewswire/ -- Ritten, a leading AI-powered system of record for behavioral health providers, today announced a $35…

2 months ago

Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology

Collaboration aims to automate RNA and protein detection in 3D tissue specimens, reducing complexity and technical barriers.Innovation has the potential…

2 months ago

LIV Recovery Center Expands Family Care & Support to Address Hidden Impact of Addiction

ALPHARETTA, GEORGIA / ACCESS Newswire / December 11, 2025 / LIV Recovery Center has launched a comprehensive Family Care &…

2 months ago

60 Degrees Pharmaceuticals Announces Expansion of ARAKODA® Sales and Marketing in 2026

6-month commercial pilot demonstrated increasing demand among prescribersExpansion plan includes doubling the number of sales reps, a new GoodRx partnership,…

2 months ago

AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio

NEW YORK and AMSTERDAM, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Atai Beckley N.V. (NASDAQ: ATAI) (“AtaiBeckley” or the “Company”), a…

2 months ago

Zocdoc Reveals Evolving Patient Preferences and Trends in Third Annual What Patients Want Report

This 2025 deep dive into patient preferences—derived from millions of Zocdoc bookings across states, specialties, and insurance plans—shows patients want…

2 months ago

FDA Approves Renewal of Canalevia-CA1, Jaguar Health’s Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs

Conditional approval extended through December 2026 for the treatment of CID in dogsCID confirmatory effectiveness trial expected to conclude in…

2 months ago

FDA Approves Renewal of Canalevia-CA1, Jaguar Health’s Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs

Conditional approval extended through December 2026 for the treatment of CID in dogsCID confirmatory effectiveness trial expected to conclude in…

2 months ago

FDA Approves Renewal of Canalevia-CA1, Jaguar Health’s Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs

Conditional approval extended through December 2026 for the treatment of CID in dogsCID confirmatory effectiveness trial expected to conclude in…

2 months ago